WebJun 23, 2024 · Circulating exosome holds great potentials as biomarker for diagnosis and prognosis of human cancers. Previously, we have applied small RNA sequencing to … WebJul 16, 2024 · Some circulating serum exosomal miRNAs were proposed as novel biomarkers for GC diagnosis, such as miR-92a-3p, miR-500a-3p, miR-1246, and miR-423-5p (3, 5, 9–12). Especially, some exosomal miRNA can be even used for GC prognosis, e.g., miR-590-5p and miR-196a-1 (3, 13). In this study, we used collected blood and …
Insights on the Biomarker Potential of Exosomal Non-Coding …
WebFurthermore, serum exosomal miR-6869-5p is a promising circulating biomarker for the prediction of CRC prognosis . miR-6869-5p was shown to inhibit cell proliferation and production of the inflammatory cytokines (TNF-α and IL-6) in CRC cells via directly targeting TLR4 . miR-6869-5p functions as a tumor suppressor through its protective effect ... WebThe best sensitivity (90.7%) and specificity (49.4%) for CSVD diagnosis when the relative expression of circulating exosomal miR-320e was taken as a cut-off value of −0.095. The result suggested a well diagnostic value of miR-320e in CSVD. Table 3 Exosomal miR-320e and the Risk Factors. green hot sauce bottle
Circulating exosomal miR-92b: Its role for cancer ... - PubMed
WebFeb 22, 2024 · Moreover, for the first time, we identified the presence of SARS-CoV-2 RNA in the exosomal cargo, which suggests that the virus might use the endocytosis route to spread infection. Our findings indicate circulating exosomes' significant contribution to several processes-such as inflammation, coagulation, and immunomodulation-during … WebApr 6, 2024 · Exosomal lipid PI4P regulates small extracellular vesicle secretion by modulating intraluminal vesicle formation ... hijack the host circulating endosome system and exploit PI4P/BLOC-1 module during the building of functional recycling endosomal tubules to their benefit (Jani et al., 2024). Modulating sEV secretion is a potential … WebFeb 1, 2024 · We evaluated the relationship between level of circulating serum exosomal PD-L1 (Sr-exosomal PD-L1) at initial diagnosis and oncologic outcome during the follow-up. Experimental Design: Sixty-seven patients with newly diagnosed osteosarcoma were prospectively recruited. fly and help reisen